deltatrials
Completed OBSERVATIONAL NCT01660776

BMS_PD-L1_onco : Assessment of the PD-L1 Protein as a Biomarker in Oncology and Hematology (BMS_PD-L1)

Sponsor: National Research Agency, France

Conditions Diffuse Large B-cell Lymphoma Hodgkin Lymphoma Metastatic Breastcancer Non-small Cell Lung Cancer
Updated 12 times since 2017 Last updated: Nov 5, 2019 Started: Jun 7, 2012 Primary completion: Oct 2, 2017 Completion: Oct 2, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Diffuse Large B-cell Lymphoma and Hodgkin Lymphoma and is currently completed. National Research Agency, France leads this study, which shows 12 recorded versions since 2012 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotRecruiting~Feb 2017 – ~Aug 2017 · 6 months · monthly snapshotRecruiting~Aug 2017 – ~Apr 2018 · 8 months · monthly snapshotRecruiting~Apr 2018 – ~May 2018 · 30 days · monthly snapshotRecruiting~May 2018 – ~Jun 2018 · 31 days · monthly snapshotActive Not Recruiting~Jun 2018 – ~Dec 2019 · 18 months · monthly snapshotActive Not Recruiting~Dec 2019 – ~Nov 2020 · 11 months · monthly snapshotCompleted~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotCompleted~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

12 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Dec 2021 — Jul 2024 [monthly]

    Completed

  4. Jan 2021 — Dec 2021 [monthly]

    Completed

  5. Nov 2020 — Jan 2021 [monthly]

    Completed

▶ Show 7 earlier versions

  1. Dec 2019 — Nov 2020 [monthly]

    Completed

    Status: Active Not Recruiting → Completed

  2. Jun 2018 — Dec 2019 [monthly]

    Active Not Recruiting

  3. May 2018 — Jun 2018 [monthly]

    Active Not Recruiting

    Status: Recruiting → Active Not Recruiting

  4. Apr 2018 — May 2018 [monthly]

    Recruiting

    Phase: NA → None

  5. Aug 2017 — Apr 2018 [monthly]

    Recruiting NA

  6. Feb 2017 — Aug 2017 [monthly]

    Recruiting NA

  7. Jan 2017 — Feb 2017 [monthly]

    Recruiting NA

    First recorded

Jun 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Research Agency, France
  • Rennes University Hospital
  • Roche Pharma AG
Data source: Rennes University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations